Host genetic factors respond to pathogenic step-specific virulence factors of Helicobacter pylori in gastric carcinogenesis

Mutation Research - Reviews in Mutation Research

Volumn 759, Issue 1, 2014, Pages 14-26

  He, Caiyun ^a   Chen, Moye ^a   Liu, Jingwei ^a   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cross talk; Gastric cancer; Helicobacter pylori; Susceptibility; Virulence factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CASPASE RECRUITMENT DOMAIN PROTEIN 4; HLA ANTIGEN CLASS 2; MUCIN 1; MUCIN 5AC; MUCIN 5B; NUCLEOLIN; PEPTIDOGLYCAN; PROTEIN TYROSINE PHOSPHATASE SHP 2; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR MARKER; UVOMORULIN; VIRULENCE FACTOR; MUCIN; PHOSPHOPROTEIN; RNA BINDING PROTEIN; TOLL LIKE RECEPTOR;

BABA GENE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CAGA GENE; CANCER RISK; CANCER SUSCEPTIBILITY; GASTRIC MUCOSA; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEREDITY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SABA GENE; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TIPALPHA GENE; TUMOR GENE; UREASE GENE; VACA GENE; CARCINOGENESIS; GENETICS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR; VIRULENCE;

CARCINOGENESIS; GASTRIC MUCOSA; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; MUCINS; PHOSPHOPROTEINS; RNA-BINDING PROTEINS; STOMACH NEOPLASMS; TOLL-LIKE RECEPTORS; VIRULENCE;

EID: 84894269557     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2013.09.002     Document Type: Review

References (144)

1. Hamajima N., Naito M., Kondo T., Goto Y. Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci. 2006, 97:1129-1138.
2. Zabaleta J. Multifactorial etiology of gastric cancer. Methods Mol. Biol. 2012, 863:411-435.
3. Rieder G., Fischer W., Haas R. Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules. Curr. Opin. Microbiol. 2005, 8:67-73.
4. Backert S., Clyne M. Pathogenesis of Helicobacter pylori infection. Helicobacter 2011, 16(Suppl. 1):19-25.
5. Gram-Negative Bacterial Infections: Advances in Research and Treatment 2011, Scholarly Editions™, Atlanta, Georgia. Q.A. Acton (Ed.).
6. Sheu B.S., Yang H.B., Yeh Y.C., Wu J.J. Helicobacter pylori colonization of the human gastric epithelium: a bug's first step is a novel target for us. J. Gastroenterol. Hepatol. 2010, 25:26-32.
7. Zanotti G., Cendron L. Functional and structural aspects of Helicobacter pylori acidic stress response factors. IUBMB Life 2010, 62:715-723.
8. Yoshiyama H., Nakazawa T. Unique mechanism of Helicobacter pylori for colonizing the gastric mucus. Microbes Infect. 2000, 2:55-60.
9. Fan X., Gunasena H., Cheng Z., Espejo R., Crowe S.E., Ernst P.B., Reyes V.E. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J. Immunol. 2000, 165:1918-1924.
10. Beswick E.J., Pinchuk I.V., Minch K., Suarez G., Sierra J.C., Yamaoka Y., Reyes V.E. The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-kappaB activation and interleukin-8 production. Infect. Immun. 2006, 74:1148-1155.
11. Lee J.E., Lowy A.M., Thompson W.A., Lu M., Loflin P.T., Skibber J.M., Evans D.B., Curley S.A., Mansfield P.F., Reveille J.D. Association of gastric adenocarcinoma with the HLA class II gene DQB10301. Gastroenterology 1996, 111:426-432.
12. Ohmori M., Yasunaga S., Maehara Y., Sugimachi K., Sasazuki T. DNA typing of HLA class I (HLA-A) and class II genes (HLA-DR, -DQ and -DP) in Japanese patients with gastric cancer. Tissue Antigens 1997, 50:277-282.
13. Wu M.S., Hsieh R.P., Huang S.P., Chang Y.T., Lin M.T., Chang M.C., Shun C.T., Sheu J.C., Lin J.T. Association of HLA-DQB1*0301 and HLA-DQB1*0602 with different subtypes of gastric cancer in Taiwan. Jpn. J. Cancer Res. 2002, 93:404-410.
14. Quintero E., Pizarro M.A., Rodrigo L., Pique J.M., Lanas A., Ponce J., Mino G., Gisbert J., Jurado A., Herrero M.J., Jimenez A., Torrado J., Ponte A., Diaz-de-Rojas F., Salido E. Association of Helicobacter pylori-related distal gastric cancer with the HLA class II gene DQB10602 and cagA strains in a southern European population. Helicobacter 2005, 10:12-21.
15. Zhao Y., Wang J., Tanaka T., Hosono A., Ando R., Soeripto S., Ediati Triningsih F.X., Triono T., Sumoharjo S., Astuti E.Y., Gunawan S., Tokudome S. Association between HLA-DQ genotypes and haplotypes vs Helicobacter pylori infection in an Indonesian population. Asian Pac. J. Cancer Prev. 2012, 13:1247-1251.
16. Magnusson P.K.E., Enroth H., Eriksson I., Held M., Nyren O., Engstrand L., Hansson L.E., Gyllensten U.B. Gastric cancer and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori. Cancer Res. 2001, 61:2684-2689.
17. Azuma T., Ito S., Sato F., Yamazaki Y., Miyaji H., Ito Y., Suto H., Kuriyama M., Kato T., Kohli Y. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 1998, 82:1013-1018.
18. Lee H.W., Hahm K.B., Lee J.S., Ju Y.S., Lee K.M., Lee K.W. Association of the human leukocyte antigen class II alleles with chronic atrophic gastritis and gastric carcinoma in Koreans. J. Dig. Dis. 2009, 10:265-271.
19. Ando T., Ishikawa T., Kato H., Yoshida N., Naito Y., Kokura S., Yagi N., Takagi T., Handa O., Kitawaki J., Nakamura N., Hasegawa G., Fukui M., Imamoto E., Nakamura C., Oyamada H., Isozaki Y., Matsumoto N., Nagao Y., Okita M., Nakajima Y., Kurokawa M., Nukina M., Ohta M., Mizuno S., Ogata M., Obayashi H., Park H., Kitagawa Y., Nakano K., Yoshikawa T. Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection. Int. J. Cancer 2009, 125:2595-2602.
20. Chen W., Sun L., Zhang Y., Bai X., Liu J., Yuan Y. HLA-DPB1 polymorphisms in population at high and low risk areas of gastric carcinoma. Chin. J. Cancer Prev. Treat. 2008, 15:807-810.
21. Mannick E.E., Schurr J.R., Zapata A., Lentz J.J., Gastanaduy M., Cote R.L., Delgado A., Correa P., Correa H. Gene expression in gastric biopsies from patients infected with Helicobacter pylori. Scand. J. Gastroenterol. 2004, 39:1192-1200.
22. Krauss-Etschmann S., Gruber R., Plikat K., Antoni I., Demmelmair H., Reinhardt D., Koletzko S. Increase of antigen-presenting cells in the gastric mucosa of Helicobacter pylori-infected children. Helicobacter 2005, 10:214-222.
23. Fan X., Crowe S.E., Behar S., Gunasena H., Ye G., Haeberle H., Van Houten N., Gourley W.K., Ernst P.B., Reyes V.E. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J. Exp. Med. 1998, 187:1659-1669.
24. Ermak T.H., Giannasca P.J., Nichols R., Myers G.A., Nedrud J., Weltzin R., Lee C.K., Kleanthous H., Monath T.P. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 1998, 188:2277-2288.
25. Ilver D., Arnqvist A., Ogren J., Frick I.M., Kersulyte D., Incecik E.T., Berg D.E., Covacci A., Engstrand L., Boren T. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998, 279:373-377.
26. Aspholm-Hurtig M., Dailide G., Lahmann M., Kalia A., Ilver D., Roche N., Vikstrom S., Sjostrom R., Linden S., Backstrom A., Lundberg C., Arnqvist A., Mahdavi J., Nilsson U.J., Velapatino B., Gilman R.H., Gerhard M., Alarcon T., Lopez-Brea M., Nakazawa T., Fox J.G., Correa P., Dominguez-Bello M.G., Perez-Perez G.I., Blaser M.J., Normark S., Carlstedt I., Oscarson S., Teneberg S., Berg D.E., Boren T. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 2004, 305:519-522.
27. Magalhaes A., Reis C.A. Helicobacter pylori adhesion to gastric epithelial cells is mediated by glycan receptors. Braz. J. Med. Biol. Res. 2010, 43:611-618.
28. Yamaoka Y. Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis. World J. Gastroenterol. 2008, 14:4265-4272.
29. Van de Bovenkamp J.H., Mahdavi J., Korteland-Van Male A.M., Buller H.A., Einerhand A.W., Boren T., Dekker J. The MUC5AC glycoprotein is the primary receptor for Helicobacter pylori in the human stomach. Helicobacter 2003, 8:521-532.
30. Van De Bovenkamp J.H., Korteland-Van Male A.M., Buller H.A., Einerhand A.W., Dekker J. Infection with Helicobacter pylori affects all major secretory cell populations in the human antrum. Dig. Dis. Sci. 2005, 50:1078-1086.
31. Kocer B., Ulas M., Ustundag Y., Erdogan S., Karabeyoglu M., Yldrm O., Unal B., Cengiz O., Soran A. A confirmatory report for the close interaction of Helicobacter pylori with gastric epithelial MUC5AC expression. J. Clin. Gastroenterol. 2004, 38:496-502.
32. de Bolos C., Real F.X., Lopez-Ferrer A. Regulation of mucin and glycoconjugate expression: from normal epithelium to gastric tumors. Front. Biosci. 2001, 6:D1256-D1263.
33. Jia Y., Persson C., Hou L., Zheng Z., Yeager M., Lissowska J., Chanock S.J., Chow W.H., Ye W. A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer. Cancer Causes Control 2010, 21:313-321.
34. Linden S., Mahdavi J., Hedenbro J., Boren T., Carlstedt I. Effects of pH on Helicobacter pylori binding to human gastric mucins: identification of binding to non-MUC5AC mucins. Biochem. J. 2004, 384:263-270.
35. Linden S.K., Sheng Y.H., Every A.L., Miles K.M., Skoog E.C., Florin T.H., Sutton P., McGuckin M.A. MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog 2009, 5:e1000617.
36. Fowler J., Vinall L., Swallow D. Polymorphism of the human muc genes. Front. Biosci. 2001, 6:D1207-D1215.
37. Carvalho F., Seruca R., David L., Amorim A., Seixas M., Bennett E., Clausen H., Sobrinho-Simoes M. MUC1 gene polymorphism and gastric cancer-an epidemiological study. Glycoconj. J. 1997, 14:107-111.
38. Silva F., Carvalho F., Peixoto A., Seixas M., Almeida R., Carneiro F., Mesquita P., Figueiredo C., Nogueira C., Swallow D.M., Amorim A., David L. MUC1 gene polymorphism in the gastric carcinogenesis pathway. Eur. J. Hum. Genet. 2001, 9:548-552.
39. Vinall L.E., King M., Novelli M., Green C.A., Daniels G., Hilkens J., Sarner M., Swallow D.M. Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology 2002, 123:41-49.
40. Costa N.R., Mendes N., Marcos N.T., Reis C.A., Caffrey T., Hollingsworth M.A., Santos-Silva F. Relevance of MUC1 mucin variable number of tandem repeats polymorphism in H. pylori adhesion to gastric epithelial cells. World J. Gastroenterol. 2008, 14:1411-1414.
41. Xu Q., Yuan Y., Sun L.P., Gong Y.H., Xu Y., Yu X.W., Dong N.N., Lin G.D., Smith P.N., Li R.W. Risk of gastric cancer is associated with the MUC1 568 A/G polymorphism. Int. J. Oncol. 2009, 35:1313-1320.
42. Abnet C.C., Freedman N.D., Hu N., Wang Z., Yu K., Shu X.O., Yuan J.M., Zheng W., Dawsey S.M., Dong L.M., Lee M.P., Ding T., Qiao Y.L., Gao Y.T., Koh W.P., Xiang Y.B., Tang Z.Z., Fan J.H., Wang C., Wheeler W., Gail M.H., Yeager M., Yuenger J., Hutchinson A., Jacobs K.B., Giffen C.A., Burdett L., Fraumeni J.F., Tucker M.A., Chow W.H., Goldstein A.M., Chanock S.J., Taylor P.R. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet. 2010, 42:764-767.
43. Shi Y., Hu Z., Wu C., Dai J., Li H., Dong J., Wang M., Miao X., Zhou Y., Lu F., Zhang H., Hu L., Jiang Y., Li Z., Chu M., Ma H., Chen J., Jin G., Tan W., Wu T., Zhang Z., Lin D., Shen H. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat. Genet. 2011, 43:1215-1218.
44. Zhang H., Jin G., Li H., Ren C., Ding Y., Zhang Q., Deng B., Wang J., Hu Z., Xu Y., Shen H. Genetic variants at 1q22 and 10q23 reproducibly associated with gastric cancer susceptibility in a Chinese population. Carcinogenesis 2011, 32:848-852.
45. Saeki N., Saito A., Choi I.J., Matsuo K., Ohnami S., Totsuka H., Chiku S., Kuchiba A., Lee Y.S., Yoon K.A., Kook M.C., Park S.R., Kim Y.W., Tanaka H., Tajima K., Hirose H., Tanioka F., Matsuno Y., Sugimura H., Kato S., Nakamura T., Nishina T., Yasui W., Aoyagi K., Sasaki H., Yanagihara K., Katai H., Shimoda T., Yoshida T., Nakamura Y., Hirohashi S., Sakamoto H. A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. Gastroenterology 2011, 140:892-902.
46. Ng W., Loh A.X., Teixeira A.S., Pereira S.P., Swallow D.M. Genetic regulation of MUC1 alternative splicing in human tissues. Br. J. Cancer 2008, 99:978-985.
47. Talarico S., Whitefield S.E., Fero J., Haas R., Salama N.R. Regulation of Helicobacter pylori adherence by gene conversion. Mol. Microbiol. 2012, 84:1050-1061.
48. Mahdavi J., Sonden B., Hurtig M., Olfat F.O., Forsberg L., Roche N., Angstrom J., Larsson T., Teneberg S., Karlsson K.A., Altraja S., Wadstrom T., Kersulyte D., Berg D.E., Dubois A., Petersson C., Magnusson K.E., Norberg T., Lindh F., Lundskog B.B., Arnqvist A., Hammarstrom L., Boren T. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002, 297:573-578.
49. Walz A., Odenbreit S., Mahdavi J., Boren T., Ruhl S. Identification and characterization of binding properties of Helicobacter pylori by glycoconjugate arrays. Glycobiology 2005, 15:700-708.
50. Frank B., Weck M.N., Muller H., Klopp N., Illig T., Raum E., Brenner H. Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis. Eur. J. Cancer 2012, 48:114-120.
51. Fischer W., Prassl S., Haas R. Virulence mechanisms and persistence strategies of the human gastric pathogen Helicobacter pylori. Curr. Top. Microbiol. Immunol. 2009, 337:129-171.
52. Muller A., Oertli M., Arnold I.C. H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection. Cell Commun. Signal. 2011, 9:25.
53. Ishii K.J., Koyama S., Nakagawa A., Coban C., Akira S. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 2008, 3:352-363.
54. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Memet S., Huerre M.R., Coyle A.J., DiStefano P.S., Sansonetti P.J., Labigne A., Bertin J., Philpott D.J., Ferrero R.L. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 2004, 5:1166-1174.
55. Ishihara S., Rumi M.A., Kadowaki Y., Ortega-Cava C.F., Yuki T., Yoshino N., Miyaoka Y., Kazumori H., Ishimura N., Amano Y., Kinoshita Y. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J. Immunol. 2004, 173:1406-1416.
56. Smith M.F., Mitchell A., Li G., Ding S., Fitzmaurice A.M., Ryan K., Crowe S., Goldberg J.B. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J. Biol. Chem. 2003, 278:32552-32560.
57. Chaput C., Ecobichon C., Cayet N., Girardin S.E., Werts C., Guadagnini S., Prevost M.C., Mengin-Lecreulx D., Labigne A., Boneca I.G. Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS Pathog 2006, 2:e97.
58. Sycuro L.K., Wyckoff T.J., Biboy J., Born P., Pincus Z., Vollmer W., Salama N.R. Multiple peptidoglycan modification networks modulate Helicobacter pylori's cell shape, motility, and colonization potential. PLoS Pathog 2012, 8:e1002603.
59. Appelmelk B.J., Vandenbroucke-Grauls C. Lipopolysaccharide Lewis Antigens, Helicobacter pylori: Physiology and Genetics 2001, ASM Press, Washington, DC.
60. Inohara N., Koseki T., del Peso L., Hu Y., Yee C., Chen S., Carrio R., Merino J., Liu D., Ni J., Nunez G. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 1999, 274:14560-14567.
61. Allison C.C., Kufer T.A., Kremmer E., Kaparakis M., Ferrero R.L. Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism. J. Immunol. 2009, 183:8099-8109.
62. Yoo N.J., Park W.S., Kim S.Y., Reed J.C., Son S.G., Lee J.Y., Lee S.H. Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem. Biophys. Res. Commun. 2002, 299:652-658.
63. Grubman A., Kaparakis M., Viala J., Allison C., Badea L., Karrar A., Boneca I.G., Le Bourhis L., Reeve S., Smith I.A., Hartland E.L., Philpott D.J., Ferrero R.L. The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides. Cell. Microbiol. 2010, 12:626-639.
64. Hofner P., Gyulai Z., Kiss Z.F., Tiszai A., Tiszlavicz L., Toth G., Szoke D., Molnar B., Lonovics J., Tulassay Z., Mandi Y. Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter 2007, 12:124-131.
65. Kara B., Akkiz H., Doran F., Bayram S., Erken E., Gumurdullu Y., Sandikci M. The significance of E266K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis?. Clin. Exp. Med. 2010, 10:107-112.
66. Wang P., Zhang L., Jiang J.M., Ma D., Tao H.X., Yuan S.L., Wang Y.C., Wang L.C., Liang H., Zhang Z.S., Liu C.J. Association of NOD1 and NOD2 genes polymorphisms with Helicobacter pylori related gastric cancer in a Chinese population. World J. Gastroenterol. 2012, 18:2112-2120.
67. Kim E.J., Lee J.R., Chung W.C., Jung S.H., Sung H.J., Lee Y.W., Oh Y.S., Kim S.B., Paik C.N., Lee K.M., Noh S.J. Association between genetic polymorphisms of NOD 1 and Helicobacter pylori-induced gastric mucosal inflammation in healthy Korean population. Helicobacter 2013, 18:143-150.
68. Kutikhin A.G. Impact of Toll-like receptor 4 polymorphisms on risk of cancer. Hum. Immunol. 2011, 72:193-206.
69. Sayi A., Kohler E., Toller I.M., Flavell R.A., Muller W., Roers A., Muller A. TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J. Immunol. 2011, 186:878-890.
70. Hold G.L., Rabkin C.S., Chow W.H., Smith M.G., Gammon M.D., Risch H.A., Vaughan T.L., McColl K.E., Lissowska J., Zatonski W., Schoenberg J.B., Blot W.J., Mowat N.A., Fraumeni J.F., El-Omar E.M. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007, 132:905-912.
71. Rigoli L., Di Bella C., Fedele F., Procopio V., Amorini M., Lo Giudice G., Romeo P., Pugliatti F., Finocchiaro G., Luciano R., Caruso R.A. TLR4 and NOD2/CARD15 genetic polymorphisms and their possible role in gastric carcinogenesis. Anticancer Res. 2010, 30:513-517.
72. Santini D., Angeletti S., Ruzzo A., Dicuonzo G., Galluzzo S., Vincenzi B., Calvieri A., Pizzagalli F., Graziano N., Ferraro E., Lorino G., Altomare A., Magnani M., Graziano F., Tonini G. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes. Clin. Exp. Immunol. 2008, 154:360-364.
73. Jing J.J., Li M., Yuan Y. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: a meta-analysis. Gene 2012, 499:237-242.
74. Schroder N.W., Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 2005, 5:156-164.
75. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000, 25:187-191.
76. Rallabhandi P., Bell J., Boukhvalova M.S., Medvedev A., Lorenz E., Arditi M., Hemming V.G., Blanco J.C., Segal D.M., Vogel S.N. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J. Immunol. 2006, 177:322-332.
77. Ferwerda B., McCall M.B., Alonso S., Giamarellos-Bourboulis E.J., Mouktaroudi M., Izagirre N., Syafruddin D., Kibiki G., Cristea T., Hijmans A., Hamann L., Israel S., ElGhazali G., Troye-Blomberg M., Kumpf O., Maiga B., Dolo A., Doumbo O., Hermsen C.C., Stalenhoef A.F., van Crevel R., Brunner H.G., Oh D.Y., Schumann R.R., de la Rua C., Sauerwein R., Kullberg B.J., van der Ven A.J., van der Meer J.W., Netea M.G. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16645-16650.
78. Yuan M., Xia J., Ma L., Xiao B., Yang Q. Lack of the Toll-like receptor 4 gene polymorphisms Asp299Gly and Thr399Ile in a Chinese population. Int. J. Neurosci. 2010, 120:415-420.
79. Tahara T., Arisawa T., Shibata T., Hirata I., Nakano H. Absence of common polymorphisms of toll like receptor 4 (TLR4): Asp299Gly, Thr399Ile in patients with gastroduodenal diseases in Japan. J. Clin. Biochem. Nutr. 2007, 40:62-65.
80. Kim Y.S., Hwang Y.J., Kim S.Y., Yang S.M., Lee K.Y., Park Ie B. Rarity of TLR4 Asp299Gly and Thr399Ile polymorphisms in the Korean population. Yonsei Med. J. 2008, 49:58-62.
81. Hishida A., Matsuo K., Goto Y., Mitsuda Y., Hiraki A., Naito M., Wakai K., Tajima K., Hamajima N. Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Helicobacter 2009, 14:47-53.
82. Sato K., Yoshimura A., Kaneko T., Ukai T., Ozaki Y., Nakamura H., Li X., Matsumura H., Hara Y., Ogata Y. A single nucleotide polymorphism in 3'-untranslated region contributes to the regulation of Toll-like receptor 4 translation. J. Biol. Chem. 2012, 287:25163-25172.
83. Tahara T., Arisawa T., Wang F., Shibata T., Nakamura M., Sakata M., Hirata I., Nakano H. Toll-like receptor 2 -196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci. 2007, 98:1790-1794.
84. Tahara T., Arisawa T., Wang F., Shibata T., Nakamura M., Sakata M., Hirata I., Nakano H. Toll-like receptor 2 (TLR) -196 to 174del polymorphism in gastro-duodenal diseases in Japanese population. Dig. Dis. Sci. 2008, 53:919-924.
85. Tahara T., Shibata T., Wang F., Yamashita H., Hirata I., Arisawa T. Genetic polymorphisms of molecules associated with innate immune responses, TRL2 and MBL2 genes in Japanese subjects with functional dyspepsia. J. Clin. Biochem. Nutr. 2010, 47:217-223.
86. de Oliveira J.G., Silva A.E. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population. World J. Gastroenterol. 2012, 18:1235-1242.
87. Hishida A., Matsuo K., Goto Y., Naito M., Wakai K., Tajima K., Hamajima N. No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese. Gastric Cancer 2010, 13:251-257.
88. Zeng H.M., Pan K.F., Zhang Y., Zhang L., Ma J.L., Zhou T., Su H.J., Li W.Q., Li J.Y., Gerhard M., Classen M., You W.C. Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a Chinese population. Cancer Epidemiol. Biomarkers Prev. 2011, 20:2594-2602.
89. Tagkalidis P.P., Royce S.G., Macrae F.A., Bhathal P.S. Selective colonization by Helicobacter pylori of the deep gastric glands and intracellular canaliculi of parietal cells in the setting of chronic proton pump inhibitor use. Eur. J. Gastroenterol. Hepatol. 2002, 14:453-456.
90. Testerman T.L., McGee D.J., Mobley H.L.T. Adherence and Colonization 2001.
91. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 2004, 4:688-694.
92. Tegtmeyer N., Wessler S., Backert S. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 2011, 278:1190-1202.
93. Hatakeyama M. Helicobacter pylori CagA-a bacterial intruder conspiring gastric carcinogenesis. Int. J. Cancer 2006, 119:1217-1223.
94. Backert S., Tegtmeyer N., Selbach M. The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter 2010, 15:163-176.
95. Higashi H., Tsutsumi R., Muto S., Sugiyama T., Azuma T., Asaka M., Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002, 295:683-686.
96. Hatakeyama M. Deregulation of SHP-2 tyrosine phosphatase by the Helicobacter pylori virulence factor CagA. Keio J. Med. 2002, 51(Suppl. 2):26-32.
97. Goto Y., Ando T., Yamamoto K., Tamakoshi A., El-Omar E., Goto H., Hamajima N. Association between serum pepsinogens and polymorphism of PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int. J. Cancer 2006, 118:203-208.
98. Hishida A., Matsuo K., Goto Y., Naito M., Wakai K., Tajima K., Hamajima N. Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobacter pylori seropositivity, gastric atrophy and gastric cancer in Japanese. BMC Gastroenterol. 2009, 9:51.
99. Kawai S., Goto Y., Ito L.S., Oba-Shinjo S.M., Uno M., Shinjo S.K., Marie S.K., Ishida Y., Nishio K., Naito M., Hamajima N. Significant association between PTPN11 polymorphism and gastric atrophy among Japanese Brazilians. Gastric Cancer 2006, 9:277-283.
100. Hamajima N., Rahimov B., Malikov Y., Abdiev S., Ahn K.S., Bahramov S., Kawai S., Nishio K., Naito M., Goto Y. Associations between a PTPN11 polymorphism and gastric atrophy-opposite in Uzbekistan to that in Japan. Asian Pac. J. Cancer Prev. 2008, 9:217-220.
101. He C., Tu H., Sun L., Xu Q., Li P., Gong Y., Dong N., Yuan Y. Helicobacter pylori-related host gene polymorphisms associated with susceptibility of gastric carcinogenesis: a two-stage case-control study in Chinese. Carcinogenesis 2013, 34:1450-1457.
102. Murata-Kamiya N., Kurashima Y., Teishikata Y., Yamahashi Y., Saito Y., Higashi H., Aburatani H., Akiyama T., Peek R.M., Azuma T., Hatakeyama M. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007, 26:4617-4626.
103. Corso G., Marrelli D., Pascale V., Vindigni C., Roviello F. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: meta analysis and systematic review of the literature. BMC Cancer 2012, 12:8.
104. Corso G., Pedrazzani C., Pinheiro H., Fernandes E., Marrelli D., Rinnovati A., Pascale V., Seruca R., Oliveira C., Roviello F. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur. J. Cancer 2011, 47:631-639.
105. Seevaratnam R., Coburn N., Cardoso R., Dixon M., Bocicariu A., Helyer L. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer. Gastric Cancer 2012, 15(Suppl. 1):S153-S163.
106. Li Y., Tang Y., Zhou R., Sun D., Duan Y., Wang N., Chen Z., Shen N. Genetic polymorphism in the 3'-untranslated region of the E-cadherin gene is associated with risk of different cancers. Mol. Carcinog. 2011, 50:857-862.
107. Zhan Z., Wu J., Zhang J.F., Yang Y.P., Tong S., Zhang C.B., Li J., Yang X.W., Dong W. CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population. Mol. Biol. Rep. 2012, 39:8107-8113.
108. Nakamura A., Shimazaki T., Kaneko K., Shibata M., Matsumura T., Nagai M., Makino R., Mitamura K. Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat. Res. 2002, 502:19-24.
109. Wang G.Y., Lu C.Q., Zhang R.M., Hu X.H., Luo Z.W. The E-cadherin gene polymorphism 160C->A and cancer risk: a HuGE review and meta-analysis of 26 case-control studies. Am. J. Epidemiol. 2008, 167:7-14.
110. Gao L., Nieters A., Brenner H. Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility. Aliment. Pharmacol. Ther. 2008, 28:565-573.
111. Wang Q., Gu D., Wang M., Zhang Z., Tang J., Chen J. The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans. DNA Cell Biol. 2011, 30:395-400.
112. Chen B., Zhou Y., Yang P., Liu L., Qin X.P., Wu X.T. CDH1-160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer. Cytokine 2011, 55:266-273.
113. Cui Y., Xue H., Lin B., Ni P., Fang J.Y. A meta-analysis of CDH1 C-160A genetic polymorphism and gastric cancer risk. DNA Cell Biol. 2011, 30:937-945.
114. Li Y.L., Tian Z., Zhang J.B., Fu B.Y. CDH1 promoter polymorphism and stomach cancer susceptibility. Mol. Biol. Rep. 2012, 39:1283-1286.
115. Wang L., Wang G., Lu C., Feng B., Kang J. Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control studies. PLoS ONE 2012, 7:e40219.
116. Li L.C., Chui R.M., Sasaki M., Nakajima K., Perinchery G., Au H.C., Nojima D., Carroll P., Dahiya R. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 2000, 60:873-876.
117. Kountouras J., Zavos C., Chatzopoulos D., Katsinelos P. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J. Surg. Res. 2008, 146:149-158.
118. Yang J.J., Cho L.Y., Ko K.P., Shin A., Ma S.H., Choi B.Y., Han D.S., Song K.S., Kim Y.S., Lee J.Y., Han B.G., Chang S.H., Shin H.R., Kang D., Yoo K.Y., Park S.K. Genetic susceptibility on CagA-interacting molecules and gene-environment interaction with phytoestrogens: a putative risk factor for gastric cancer. PLoS ONE 2012, 7:e31020.
119. Yang J.J., Cho L.Y., Ma S.H., Ko K.P., Shin A., Choi B.Y., Han D.S., Song K.S., Kim Y.S., Chang S.H., Shin H.R., Kang D., Yoo K.Y., Park S.K. Oncogenic CagA promotes gastric cancer risk via activating ERK signaling pathways: a nested case-control study. PLoS ONE 2011, 6:e21155.
120. Palframan S.L., Kwok T., Gabriel K. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front. Cell Infect. Microbiol. 2012, 2:92.
121. Kim I.J., Blanke S.R. Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA). Front. Cell Infect. Microbiol. 2012, 2:37.
122. Isomoto H., Moss J., Hirayama T. Pleiotropic actions of Helicobacter pylori vacuolating cytotoxin, VacA. Tohoku J. Exp. Med. 2010, 220:3-14.
123. Yahiro K., Niidome T., Kimura M., Hatakeyama T., Aoyagi H., Kurazono H., Imagawa K., Wada A., Moss J., Hirayama T. Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta. J. Biol. Chem. 1999, 274:36693-36699.
124. Hirayama T. Protein tyrosine phosphatase beta, a receptor for Helicobacter pylori vacA toxin. Keio J. Med. 2002, 51(Suppl. 2):20-23.
125. Yahiro K., Wada A., Nakayama M., Kimura T., Ogushi K., Niidome T., Aoyagi H., Yoshino K., Yonezawa K., Moss J., Hirayama T. Protein-tyrosine phosphatase alpha, RPTP alpha, is a Helicobacter pylori VacA receptor. J. Biol. Chem. 2003, 278:19183-19189.
126. Nakayama M., Hisatsune J., Yamasaki E., Nishi Y., Wada A., Kurazono H., Sap J., Yahiro K., Moss J., Hirayama T. Clustering of Helicobacter pylori VacA in lipid rafts, mediated by its receptor, receptor-like protein tyrosine phosphatase beta, is required for intoxication in AZ-521 cells. Infect. Immun. 2006, 74:6571-6580.
127. Suganuma M., Kurusu M., Okabe S., Sueoka N., Yoshida M., Wakatsuki Y., Fujiki H. Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori. Cancer Res. 2001, 61:6356-6359.
128. Watanabe T., Tsuge H., Imagawa T., Kise D., Hirano K., Beppu M., Takahashi A., Yamaguchi K., Fujiki H., Suganuma M. Nucleolin as cell surface receptor for tumor necrosis factor-alpha inducing protein: a carcinogenic factor of Helicobacter pylori. J. Cancer Res. Clin. Oncol. 2010, 136:911-921.
129. Kuzuhara T., Suganuma M., Oka K., Fujiki H. DNA-binding activity of TNF-alpha inducing protein from Helicobacter pylori. Biochem. Biophys. Res. Commun. 2007, 362:805-810.
130. Jang J.Y., Yoon H.J., Yoon J.Y., Kim H.S., Lee S.J., Kim K.H., Kim do J., Jang S., Han B.G., Lee B.I., Suh S.W. Crystal structure of the TNF-alpha-Inducing protein (Tipalpha) from Helicobacter pylori: insights into Its DNA-binding activity. J. Mol. Biol. 2009, 392:191-197.
131. Tajrishi M.M., Tuteja R., Tuteja N. Nucleolin The most abundant multifunctional phosphoprotein of nucleolus. Commun. Integr. Biol. 2011, 4:267-275.
132. Suganuma M., Watanabe T., Yamaguchi K., Takahashi A., Fujiki H. Human gastric cancer development with TNF-alpha-inducing protein secreted from Helicobacter pylori. Cancer Lett. 2012, 322:133-138.
133. Rad R., Gerhard M., Lang R., Schoniger M., Rosch T., Schepp W., Becker I., Wagner H., Prinz C. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J. Immunol. 2002, 168:3033-3041.
134. Ishijima N., Suzuki M., Ashida H., Ichikawa Y., Kanegae Y., Saito I., Boren T., Haas R., Sasakawa C., Mimuro H. BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. J. Biol. Chem. 2011, 286:25256-25264.
135. Senkovich O.A., Yin J., Ekshyyan V., Conant C., Traylor J., Adegboyega P., McGee D.J., Rhoads R.E., Slepenkov S., Testerman T.L. Helicobacter pylori AlpA and AlpB bind host laminin and influence gastric inflammation in gerbils. Infect. Immun. 2011, 79:3106-3116.
136. Yamaoka Y., Kwon D.H., Graham D.Y. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:7533-7538.
137. Dossumbekova A., Prinz C., Mages J., Lang R., Kusters J.G., Van Vliet A.H., Reindl W., Backert S., Saur D., Schmid R.M., Rad R. Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. J. Infect. Dis. 2006, 194:1346-1355.
138. Wang G., Maier S.E., Lo L.F., Maier G., Dosi S., Maier R.J. Peptidoglycan deacetylation in Helicobacter pylori contributes to bacterial survival by mitigating host immune responses. Infect. Immun. 2010, 78:4660-4666.
139. Pece S., Giuliani G., Di Leo A., Fumarola D., Antonaci S., Jirillo E. Role of lipopolysaccharide and related cytokines in Helicobacter pylori infection. Recenti Prog. Med. 1997, 88:237-241.
140. Lee S.K., Stack A., Katzowitsch E., Aizawa S.I., Suerbaum S., Josenhans C. Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect. 2003, 5:1345-1356.
141. Wang G., Alamuri P., Maier R.J. The diverse antioxidant systems of Helicobacter pylori. Mol. Microbiol. 2006, 61:847-860.
142. Tosi T., Cioci G., Jouravleva K., Dian C., Terradot L. Structures of the tumor necrosis factor alpha inducing protein Tipalpha: a novel virulence factor from Helicobacter pylori. FEBS Lett. 2009, 583:1581-1585.
143. Dan K., Yuehua G., Yanmei Z., Aodi L., Nannan D., Ying P., Yuan Y. The biological activity of H. pylori SlyD in vitro. Helicobacter 2013, 18:347-355.
144. Chamaillard M., Hashimoto M., Horie Y., Masumoto J., Qiu S., Saab L., Ogura Y., Kawasaki A., Fukase K., Kusumoto S., Valvano M.A., Foster S.J., Mak T.W., Nunez G., Inohara N. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 2003, 4:702-707.